Assessment of vascular endothelial function lacks consistency, and microvascular endothelial function has been only partly assessed in heart failure with preserved ejection fraction (HFpEF)
Renal dysfunction in heart failure with preserved ejection fraction (HFpEF) is common and is associa...
Renal dysfunction in heart failure with preserved ejection fraction (HFpEF) is common and is associa...
Renal dysfunction in heart failure with preserved ejection fraction (HFpEF) is common and is associa...
Heart failure with preserved ejection fraction (HFpEF) has been recognized as the greatest single un...
10.1016/j.jacc.2012.08.004Journal of the American College of Cardiology60181787-1789JACC
Heart failure with preserved ejection fraction (HFpEF) is an increasingly studied entity accounting ...
Outcomes for heart failure (HF) patients remain suboptimal. No known therapy improves mortality in a...
The purpose of this study was to evaluate whether heart failure with mildly reduced ejection fractio...
Heart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern ...
Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) wit...
Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) wit...
Background: Endothelial dysfunction is a key mechanism in the development of cardiac remodelling and...
Heart failure with preserved ejection fraction (HFpEF) is a condition with increasing incidence, lea...
Heart failure (HF) is a growing public health burden, with high prevalence and mortality rates. A pr...
Heart failure (HF) has been classified as reduced ejection fraction (HFrEF), mildly reduced ejection...
Renal dysfunction in heart failure with preserved ejection fraction (HFpEF) is common and is associa...
Renal dysfunction in heart failure with preserved ejection fraction (HFpEF) is common and is associa...
Renal dysfunction in heart failure with preserved ejection fraction (HFpEF) is common and is associa...
Heart failure with preserved ejection fraction (HFpEF) has been recognized as the greatest single un...
10.1016/j.jacc.2012.08.004Journal of the American College of Cardiology60181787-1789JACC
Heart failure with preserved ejection fraction (HFpEF) is an increasingly studied entity accounting ...
Outcomes for heart failure (HF) patients remain suboptimal. No known therapy improves mortality in a...
The purpose of this study was to evaluate whether heart failure with mildly reduced ejection fractio...
Heart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern ...
Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) wit...
Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) wit...
Background: Endothelial dysfunction is a key mechanism in the development of cardiac remodelling and...
Heart failure with preserved ejection fraction (HFpEF) is a condition with increasing incidence, lea...
Heart failure (HF) is a growing public health burden, with high prevalence and mortality rates. A pr...
Heart failure (HF) has been classified as reduced ejection fraction (HFrEF), mildly reduced ejection...
Renal dysfunction in heart failure with preserved ejection fraction (HFpEF) is common and is associa...
Renal dysfunction in heart failure with preserved ejection fraction (HFpEF) is common and is associa...
Renal dysfunction in heart failure with preserved ejection fraction (HFpEF) is common and is associa...